Skip to content

D.I.: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

D.I.

BE 0431.579.328
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€283,532
2024 · €68,679+€214,853
Equity
€3.7m
2024 · €3.4m+€283,532
Cash
€1.5m
2024 · €127,611+€1.4m
Balance sheet total
€3.7m
2024 · €3.4m+€256,216

Largest movements

2024 to 2025
Assets
  • Current investments -€1.4m

    down €1.4m (-57.7%), from €2.5m to €1.0m

  • Cash +€1.4m

    up €1.4m (+1,105%), from €127,611 to €1.5m

    mainly Current investments (+€1.4m) and Net result for the year (+€283,532)

  • Stocks and contracts +€246,198

    new in 2025: €246,198

Equity and liabilities
  • Reserves +€283,532

    up €283,532 (+8.6%), from €3.3m to €3.6m

    of which Distributable reserves: +€283,532

Income statement
  • Financial income +€272,469

    up €272,469 (+321%), from €84,813 to €357,283

  • Gross operating margin -€100,049

    down €100,049, from €69,194 to -€30,855

  • Financial charges -€40,903

    down €40,903, from €23,955 to -€16,948

  • Taxes -€3,547

    down €3,547 (-8.7%), from €40,912 to €37,365

  • Other operating charges +€1,459

    up €1,459 (+106%), from €1,373 to €2,832

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €68,679
Gross operating margin -€100,049
Depreciation -€558
Other operating charges -€1,459
Financial income +€272,469
Financial charges +€40,903
Taxes +€3,547
Result 2025 €283,532
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€2,123
Investment +€1.4m
Financing €0
Cash 2024 €127,611
Net result for the year +€283,532
Depreciation +€19,647
Stocks and contracts -€246,198
Receivables within one year -€35,134
Smaller working-capital items +€6,420
Trade debts -€18,504
Other debts -€11,886
Investment in fixed assets (net) -€1,743
Current investments +€1.4m
Cash 2025 €1.5m
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,435,698 €3,691,913 +€256,216 +7.5%
Fixed assets 21/28 €496,723 €478,819 -€17,904 -3.6%
Tangible fixed assets 22/27 €198,882 €180,978 -€17,904 -9.0%
Land and buildings 22 €157,164 €151,914 -€5,250 -3.3%
Plant, machinery and equipment 23 €2,445 €1,875 -€570 -23.3%
Furniture and vehicles 24 €39,273 €27,189 -€12,084 -30.8%
Financial fixed assets 28 €297,842 €297,842 = 0.0%
Current assets 29/58 €2,938,975 €3,213,094 +€274,119 +9.3%
Stocks and contracts in progress 3 - €246,198 +€246,198
Stocks 30/36 - €246,198 +€246,198
Amounts receivable within one year 40/41 €355,095 €390,229 +€35,134 +9.9%
Trade receivables 40 €13,061 - -€13,061
Other amounts receivable 41 €342,034 €390,229 +€48,195 +14.1%
Current investments 50/53 €2,452,923 €1,038,438 -€1.4m -57.7%
Cash at bank and in hand 54/58 €127,611 €1,538,229 +€1.4m +1,105%
Deferred charges and accrued income 490/1 €3,346 - -€3,346
Total equity and liabilities 10/49 €3,435,698 €3,691,913 +€256,216 +7.5%
Equity 10/15 €3,375,467 €3,658,999 +€283,532 +8.4%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €3,313,467 €3,596,999 +€283,532 +8.6%
Non-distributable reserves 130/1 €54,645 €54,645 = 0.0%
Legal reserve 130 €54,645 €54,645 = 0.0%
Tax-exempt reserves 132 €37,500 €37,500 = 0.0%
Distributable reserves 133 €3,221,323 €3,504,855 +€283,532 +8.8%
Amounts payable 17/49 €60,231 €32,914 -€27,317 -45.4%
Amounts payable within one year 42/48 €60,231 €32,914 -€27,317 -45.4%
Trade debts 44 €23,065 €4,561 -€18,504 -80.2%
Suppliers 440/4 €23,065 €4,561 -€18,504 -80.2%
Taxes, remuneration and social security 45 €25,280 €28,353 +€3,073 +12.2%
Taxes 450/3 €25,280 €28,353 +€3,073 +12.2%
Other amounts payable 47/48 €11,886 - -€11,886
Non-recurring operating income 76A €104,414 - -€104,414
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €19,089 €19,647 +€558 +2.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €0 - =
Other operating charges 640/8 €1,373 €2,832 +€1,459 +106%
Non-recurring operating charges 66A €0 - =
Gross operating margin 9900 €69,194 -€30,855 -€100,049
Operating profit (loss) 9901 €48,733 -€53,333 -€102,066
Financial income 75/76B €84,813 €357,283 +€272,469 +321%
Recurring financial income 75 €84,813 €357,283 +€272,469 +321%
Financial charges 65/66B €23,955 -€16,948 -€40,903
Recurring financial charges 65 €23,955 -€16,948 -€40,903
Profit (loss) for the period before taxes 9903 €109,591 €320,897 +€211,307 +193%
Income taxes 67/77 €40,912 €37,365 -€3,547 -8.7%
Profit (loss) for the period 9904 €68,679 €283,532 +€214,853 +313%
Profit (loss) for the period to be appropriated 9905 €68,679 €283,532 +€214,853 +313%

Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.